Trial-Based Costs for Interventions to Improve HPV Vaccine Uptake

Full Article URL: <a target="_blank" href="https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842992">https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2842992
Textarea URL (this page): <a href="https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKUaWyC9IzdNPK83JSSwqyUzOSdU3sjAxsrQ0AgCOMhlm_2025-12-19">https://textarea.nl/i/eNrLKCkpKLbS189KzE3MSy0pzy_K1kvOz9XPyi8tykvMKUaWyC9IzdNPK83JSSwqyUzOSdU3sjAxsrQ0AgCOMhlm_2025-12-19
Source: https://jamanetwork.com/rss/site_214/187.xml
Jamanetwork.com Open: https://jamanetwork.com/journals/jamanetworkopen
Publication date: 2025-12-19 00:00:00
Last retrieval: 2025-12-20 05:45:30.730755

00:00 - 19 Dec 2025

This economic evaluation estimates the implementation costs and cost per additional patient receiving the vaccine associated with each of the intervention strategies for increasing rates of human papillomavirus (HPV) vaccination in primary care practices.